Latest 10-K annual reports

NASDAQ
CytoSorbents Corporation files its 2024 10-K, highlighting revenue growth, reduced operating losses, and progress towards regulatory approval for DrugSorb-ATR.
LQR House Inc.'s 2024 annual report reveals substantial net losses and raises concerns about the company's ability to continue as a going concern, despite increased revenue and strategic acquisitions.
OTC.Pink
Crown Electrokinetics Corp. reports a significant revenue increase driven by its Fiber Optics and Water Solutions divisions, but faces challenges including a Nasdaq delisting and ongoing financial losses.
OTC.Pink
Miami Breeze Car Care Inc. reports a net loss for 2024 and announces the acquisition of Gin City Group, a luxury lifestyle company.
AMEX
PEDEVCO Corp. files its 10-K for fiscal year 2024, including restated financial statements for 2022 and 2023 due to an error in calculating depletion expense.
Leafly Holdings reports a net loss for 2024, grapples with delisting from Nasdaq, and expresses substantial doubt about its ability to continue as a going concern.
New Era Helium Inc. aims to become a leading helium and natural gas supplier, transitioning from a hydrocarbon focus to a helium-centric model with the construction of its Pecos Slope Plant.
Amaze Holdings, formerly Fresh Vine Wine, reports a significant decrease in revenue for FY2024, navigates a recent acquisition, and addresses concerns about its ability to continue as a going concern.
iCAD Inc. reports a 13.2% increase in revenue for 2024, driven by growth in product and license sales and strategic initiatives.
NASDAQ
Newbury Street II Acquisition Corp's Form 10-K filing details the company's registered securities as of December 31, 2024, including units, Class A Ordinary Shares, and public warrants.
General Enterprise Ventures, Inc. (GEVI) reports increased revenue for 2024 driven by commercialization of its CitroTech products, but continues to experience net losses and relies on debt financing.
Longevity Health Holdings, Inc. reports its 2024 financial results, highlighting a strategic shift towards bio-aesthetics and addressing concerns about its ability to continue as a going concern.
NYSE
Spruce Power's 2024 10-K filing reveals a year of strategic acquisitions and operational improvements amidst financial challenges and regulatory scrutiny.
NASDAQ
SolarMax Technology reports a significant revenue decline, a substantial net loss, and ongoing concerns about its ability to continue as a going concern, alongside identified material weaknesses in its internal controls.
NYSE
Abercrombie & Fitch Co. files its 10-K report, highlighting a successful fiscal year with significant sales growth and strategic initiatives for future expansion.
NASDAQ
Talphera, Inc.'s FY 2024 10-K filing reveals ongoing financial losses and a need for additional capital, balanced by progress in product development and strategic divestments.
Klotho Neurosciences enters into a securities purchase agreement for \$2.17 million via senior convertible notes and warrants to fund general corporate purposes.
AMEX
Actinium Pharmaceuticals' 2024 annual report details the company's financial results, pipeline advancements, and strategic focus on targeted radiotherapies for advanced cancers.
Valuence Merger Corp. I reports its annual results on Form 10-K, highlighting its ongoing efforts to find a suitable business combination target amidst challenges including a Nasdaq delisting and limited operational runway.
NASDAQ
Celcuity Inc.'s 10-K filing provides a detailed overview of its capital stock structure, outstanding warrants, and measures in place to deter potential takeovers as of December 31, 2024.
OTC.Pink
Freeze Tag, Inc. reports a net loss of $492,605 for 2024 and is exploring strategic options due to increased costs of being a public company.
NASDAQ
BT Brands saw a revenue increase in 2024, driven by acquisitions and same-store sales growth, but also experienced a larger net loss due to impairment charges and increased operating costs.
AMEX
Sachem Capital Corp. reports a net loss for 2024 due to various factors, including realized losses on loan sales and increased provisions for credit losses, while also addressing covenant compliance issues and strategic shifts.
NexPoint Capital, Inc. releases its 10-K filing, detailing investment activities and financial performance for the year ended December 31, 2024, highlighting a portfolio of middle-market healthcare and other sector investments.
T1 Energy Inc. completed the acquisition of Trina Solar's U.S. assets, initiated solar module production, and advanced plans for a U.S. solar cell manufacturing facility in 2024, marking a significant shift towards integrated U.S.-based solar manufacturing.
OTC.Pink
Yotta Acquisition Corporation's 10-K filing reveals substantial doubt about its ability to continue as a going concern, despite entering a merger agreement with DRIVEiT Financial Auto Group, due to an approaching deadline for completing a business combination and material weaknesses in internal controls.
AMEX
LGL Group's 2024 10-K filing reveals increased revenues driven by electronic instruments and strategic investments, offset by higher expenses and a potential capital raise.
NASDAQ
MDB Capital Holdings reports its FY2024 financial results, highlighting the deconsolidation of eXoZymes, strategic shifts in operations, and ongoing efforts to strengthen internal controls.
NYSE
Seritage Growth Properties reports its 10-K filing, highlighting ongoing asset sales and strategic plan execution amid challenging market conditions.
NASDAQ
Microvast Holdings, Inc. announces a 24% increase in revenue for 2024, but grapples with funding delays for its Clarksville, Tennessee facility and identifies a material weakness in internal controls.